The AVERROES-MRI assessment study (2016) showed a nonsignificant trend towards reduced ischemic stroke and covert embolic-pattern infarction with apixaban compared to aspirin, with no increase in microbleeds [ 85 ].
← all excerpts
Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling.
1
—
—